© 2024. 代谢相关脂肪性肝病临床科研与疾病管理大数据共享平台
| 论文标题 | 作者 | 发表时间 | 发表杂志 | 影响因子 |
|---|---|---|---|---|
| Hexokinase 2-mediated metabolic stress and inflammation burden of liver macrophages via histone lactylation in MASLD | Jinyang Li, Xiancheng Chen, Shiyu Song, Wangjie Jiang, Tianjiao Geng, Tiantian Wang, Yan Xu, Yongqiang Zhu, Jun Lu, Yongxiang Xia, Rong Wang. |
2025-03 |
Cell reports |
7.5 |
| FGF21 reverses MASH through coordinated actions on the CNS and liver | Jesse P Rose, Donald A Morgan, Andrew I Sullivan, Xiaorong Fu, Melissa Inigo-Vollmer, Shawn C Burgess, David K Meyerholz, Kamal Rahmouni, Matthew J Potthoff. |
2025-05 |
Cell metabolism |
27.7 |
| Hepatic AKAP1 deficiency exacerbates diet-induced MASLD by enhancing GPAT1-mediated lysophosphatidic acid synthesis | Linjie He, Xiaojuan She, Lifei Guo, Mingshu Gao, Shuangbin Wang, Zhenxing Lu, Haitao Guo, Renlong Li, Yongzhan Nie, Jinliang Xing, Lele Ji. |
2025-05 |
Nature communications |
14.7 |
| The Protective Effect of FOXO3 rs2802292 G-Allele on Food Intake in a Southern Italian Cohort Affected by MASLD | Rossella Donghia, Elisabetta Di Nicola, Rossella Tatoli, Giovanna Forte, Martina Lepore Signorile, Caterina Bonfiglio, Marialaura Latrofa, Katia De Marco, Andrea Manghisi, Vittoria Disciglio, Candida Fasano, Paola Sanese, Filomena Cariola, Antonia Lucia Buonadonna, Gianluigi Giannelli, Valentina Grossi, Cristiano Simone. |
2025-04 |
Nutrients |
4.8 |
| The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity | Sofia Tamini, Adele Bondesan, Diana Caroli, Nicoletta Marazzi, Alessandro Sartorio. |
2025-03 |
Journal of clinical medicine |
3.0 |
| Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment | Zisis M, Chondrogianni ME, Androutsakos T, Rantos I, Oikonomou E, Chatzigeorgiou A, Kassi E. |
2025-02 |
Biomolecules |
4.8 |
| Full-length 16S rRNA Sequencing Reveals Gut Microbiome Signatures Predictive of MASLD in children with obesity | Yu-Cheng Lin, Chi-Chien Wu, Yun-Er Li, Chun-Liang Chen, Chia-Ray Lin, Yen-Hsuan Ni |
2025-03 |
BMC Microbiology |
4 |
| Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities | Tom Ryu, Young Chang, Jeong-Ju Yoo, Sae Hwan Lee Soung Won Jeong, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Keungmo Yang, Jae Young Jang |
2025-02 |
Clinical nutrition |
6.6 |
| Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis | Crane H, Eslick GD, Gofton C, Shaikh A, Cholankeril G, Cheah M, Zhong JH, Svegliati-Baroni G, Vitale A, Kim BK, Ahn SH, Kim MN, Strasser SI, George J. |
2024-04 |
Clinical and molecular hepatology |
14 |
| Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. | Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L. |
2024-01 |
Journal of hepatology |
26.8 |
